The US Food and Drug Administration (FDA) has warned users not to use Cue Health’s at-home Covid-19 tests, just one week after the agency issued a warning letter saying that Cue was not following the ...

Cue Health Inc. CEO Ayub Khattak joins Yahoo Finance Live to discuss how his company has adapeted its COVID-19 test to fit the growing demand. ZACK GUZMAN: Welcome back to Yahoo Finance Live.

The FDA has issued its first emergency use authorization for a COVID-19 molecular diagnostic test that does not require a prescription and can be used at home. Developed by Cue Health, the Cue ...

Home diagnostics company Cue Health announced its received FDA de novo authorization for its at-home COVID-19 test, dubbed the Cue COVID-19 Molecular Test. The Cue COVID-19 Molecular Test detects ...

Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) for its ...

Cue Health, a healthcare technology company, announced it has received regulatory approval from The Central Drugs Standard Control Organisation (CDSCO) for the Cue Covid-19 Test for professional point ...

Fresh off a $100 million Series C funding round, molecular diagnostics startup Cue Health has more good news — it has received an Emergency Use Authorization (EUA) for its rapid, point-of-care ...

The FDA has extended the shelf life for some COVID-19 tests. Now that allergy season is here, many are finding themselves with symptoms asking: Is it allergies or a cold? COVID? Something else? Since ...

The test will be designed to detect and differentiate between the four viruses and deliver results in approximately 25 minutes Cue Health (Nasdaq: HLTH), a healthcare technology company, today ...